Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisatracurium dosing by FFM vs TBW vs IBW in bariatric surgery
IRCT20151107024909N9Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of cisatracurium in obesity (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Duration of anaesthesia, Time of TOF and 1 more. Started Jan 2020; status: completed.
02
Drugs
cisatracurium
03
Conditions
obesity
Beyond the preview
Go deeper on IRCT20151107024909N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151107024909N9.